Clinical Trial Update: Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial update examines whether transdermal nicotine could modify disease progression in early Parkinson's disease. The current status of the trial is u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Nicotine transdermal patch (nicotine patch)

Snippet

Sponsor: James BOYD MD | Conditions: Parkinson's Disease | Phase 2 | Status: UNKNOWN